Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 21, 2025 4
3 Oct 21, 2025 3
S-8 Oct 20, 2025 S-8
8-K Oct 14, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
10-Q Aug 12, 2025 10-Q
8-K Aug 12, 2025 8-K
4 Aug 5, 2025 4
4 Aug 5, 2025 4
144 Aug 4, 2025
144 Aug 4, 2025
SCHEDULE 13G/A Jul 29, 2025
3 Jul 3, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Jul 3, 2025
8-K/A Jun 17, 2025 8-K/A
S-8 Jun 4, 2025 S-8
4 May 30, 2025 OWNERSHIP DOCUMENT
4 May 30, 2025 OWNERSHIP DOCUMENT
8-K May 30, 2025 8-K
4 May 30, 2025 4
4 May 30, 2025 4
4 May 30, 2025 4
4 May 30, 2025 4
4 May 30, 2025 4
← Newer Page 3 of 34 · 848 filings Older →